Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Global Market Report 2026

Description

Messenger ribonucleic acid (mRNA) synthesis and manufacturing is a biotechnological process involving the design, production, and purification of mRNA molecules at scale for use in therapeutics and vaccines. This process includes transcribing synthetic DNA templates into mRNA through enzymatic reactions, followed by purification, formulation, and quality control to ensure the mRNA is stable, effective, and safe for clinical or commercial applications.

The primary types of mRNA synthesis and manufacturing are mRNA drug synthesis and mRNA vaccine synthesis. mRNA drug synthesis encompasses the laboratory and industrial procedures for designing, synthesizing, and producing mRNA sequences intended for therapeutic use. These processes are carried out at multiple scales, including preclinical, clinical, and commercial stages. The applications cover various therapeutic areas such as infectious diseases, oncology, and others, and support uses including vaccine production, therapeutic development, drug discovery, and more.

Tariffs have affected the mRNA synthesis and manufacturing market by increasing costs of imported raw materials, enzymes, nucleotides, and LNP formulation components. Commercial-scale and GMP-compliant mRNA production segments are particularly impacted, with regions such as North America and Europe experiencing higher import duties. This has led to elevated production costs and supply chain delays. On the positive side, tariffs have encouraged local sourcing, investment in domestic production infrastructure, and innovation in alternative reagents and materials.

The messenger ribonucleic acid (mrna) synthesis and manufacturing market research report is one of a series of new reports from The Business Research Company that provides messenger ribonucleic acid (mrna) synthesis and manufacturing market statistics, including messenger ribonucleic acid (mrna) synthesis and manufacturing industry global market size, regional shares, competitors with a messenger ribonucleic acid (mrna) synthesis and manufacturing market share, detailed messenger ribonucleic acid (mrna) synthesis and manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the messenger ribonucleic acid (mrna) synthesis and manufacturing industry. This messenger ribonucleic acid (mrna) synthesis and manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The messenger ribonucleic acid (mrna) synthesis and manufacturing market size has grown rapidly in recent years. It will grow from $5.14 billion in 2025 to $5.79 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to limited availability of mRNA synthesis platforms, early-stage research in mRNA therapeutics, reliance on small-scale laboratory production, nascent regulatory frameworks, high cost of purification and formulation services.

The messenger ribonucleic acid (mrna) synthesis and manufacturing market size is expected to see rapid growth in the next few years. It will grow to $9.22 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to technological advancements in automated mRNA synthesis, expansion of commercial-scale mRNA manufacturing facilities, rising investment in vaccine and therapeutic pipelines, increasing demand for self-amplifying mRNA and novel formulations, growth in preclinical and clinical research collaborations. Major trends in the forecast period include increasing adoption of gmp-compliant mrna synthesis, rising demand for large-scale mrna production, expansion of mrna therapeutics and vaccine pipelines, enhanced focus on purification capping and tailing services, growing integration of mrna-lnp formulations and stability testing.

The rising prevalence of infectious diseases is expected to drive growth in the messenger ribonucleic acid (mRNA) synthesis and manufacturing market in the coming years. Infectious diseases are disorders caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, including illnesses like malaria that can spread directly or indirectly. The increasing prevalence of these diseases is largely due to rapid urbanization, which results in higher population density and closer human contact, facilitating the spread of infections. mRNA synthesis and manufacturing play a critical role in combating infectious diseases by enabling the rapid development and scalable production of targeted vaccines and therapeutics that elicit specific immune responses. For example, in October 2024, the World Health Organization, a Switzerland-based international public health organization, reported that approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, up from about 7.5 million in 2022, making tuberculosis the leading infectious disease killer. This indicates that the growing prevalence of infectious diseases is fueling growth in the mRNA synthesis and manufacturing market.

Key companies in the mRNA synthesis and manufacturing market are focusing on innovative products, such as co-transcriptional capping platforms, to accelerate preclinical research and reduce regulatory hurdles. A co-transcriptional capping platform is a proprietary method that efficiently attaches a protective cap to mRNA molecules during synthesis, improving stability, translation efficiency, and control over immunogenicity. For instance, in May 2025, GenScript, a U.S.-based life sciences research tools company, launched its GMP-like mRNA manufacturing service. This scalable, regulatory-aware service produces high-purity, functional mRNA for investigational new drug (IND)-enabling preclinical studies, including toxicology, biodistribution, and pharmacokinetic or pharmacodynamic assessments. Built in cleanroom-compliant, ISO 7-classified environments, the service incorporates patented co-transcriptional capping technology and delivers customized mRNA in as little as seven weeks. This solution bridges the gap between research-grade and full GMP manufacturing, enabling early-stage biotechnology and pharmaceutical companies to conduct regulatory-aligned studies efficiently and cost-effectively.

In June 2024, BioNTech, a Germany-based biotechnology company, acquired CureVac for an undisclosed sum. Through this acquisition, BioNTech aims to combine CureVac's proprietary mRNA technology, RNA printer platform, and clinical pipeline with its own global infrastructure and development capabilities to strengthen its position in infectious diseases and oncology. CureVac is a Germany-based biopharmaceutical company specializing in mRNA synthesis and manufacturing.

Major companies operating in the messenger ribonucleic acid (mrna) synthesis and manufacturing market are Thermo Fisher Scientific Inc., Evonik Industries AG, Moderna Inc., BioNTech SE , AGC Biologics A/S, Eurofins Scientific SE, Lonza Group AG, Catalent Inc., WuXi Biologics (Cayman) Inc., Samsung Biologics Co Ltd., GenScript Biotech Corporation, Arcturus Therapeutics Holdings Inc., New England Biolabs Inc., CureVac N.V., Abzena plc, Creative Biolabs Inc., Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC

North America was the largest region in the messenger ribonucleic acid (mRNA) synthesis and manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the messenger ribonucleic acid (mrna) synthesis and manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the messenger ribonucleic acid (mrna) synthesis and manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The messenger ribonucleic acid (mRNA) synthesis and manufacturing market consists of sales of synthetic deoxyribonucleic acid (DNA) templates, in vitro transcription kits, enzymes, nucleotides, purification systems, and formulation reagents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses messenger ribonucleic acid (mrna) synthesis and manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for messenger ribonucleic acid (mrna) synthesis and manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The messenger ribonucleic acid (mrna) synthesis and manufacturing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Service Type: Messenger Ribonucleic Acid (mRNA) Drug Synthesis; Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis
2) By Scale Of Operation: Preclinical; Clinical; Commercial
3) By Therapeutic Area: Infectious Diseases; Oncology; Other Therapeutic Areas
4) By Application: Vaccine Production; Therapeutic Development; Drug Discovery; Other Applications
Subsegments:
1) By Messenger Ribonucleic Acid (mRNA) Drug Synthesis: Custom Messenger Ribonucleic Acid (mRNA) Synthesis; GMP-Grade Messenger Ribonucleic Acid (mRNA) Synthesis; Large-Scale Messenger Ribonucleic Acid (mRNA) Synthesis; Modified Messenger Ribonucleic Acid (mRNA) Synthesis; Capping And Tailing Services; Purification Services
2) By Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis: Preclinical Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis; Clinical-Grade Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis; GMP-Compliant Vaccine Batch Production; Self-Amplifying Messenger Ribonucleic Acid (mRNA) Synthesis; Messenger Ribonucleic Acid (mRNA)-LNP Formulation Services For Vaccines; Stability Testing And QC Services
Companies Mentioned: Thermo Fisher Scientific Inc.; Evonik Industries AG; Moderna Inc.; BioNTech SE ; AGC Biologics A/S; Eurofins Scientific SE; Lonza Group AG; Catalent Inc.; WuXi Biologics (Cayman) Inc.; Samsung Biologics Co Ltd.; GenScript Biotech Corporation; Arcturus Therapeutics Holdings Inc.; New England Biolabs Inc.; CureVac N.V.; Abzena plc; Creative Biolabs Inc.; Aldevron LLC; eTheRNA immunotherapies NV; Bio-Synthesis Inc.; TriLink BioTechnologies LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH3MMRAM02_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Industry 4.0 & Intelligent Manufacturing
- 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.4 Artificial Intelligence & Autonomous Intelligence
- 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
- 4.2.1 Increasing Adoption Of Gmp-Compliant Mrna Synthesis
- 4.2.2 Rising Demand For Large-Scale Mrna Production
- 4.2.3 Expansion Of Mrna Therapeutics And Vaccine Pipelines
- 4.2.4 Enhanced Focus On Purification, Capping, And Tailing Services
- 4.2.5 Growing Integration Of Mrna-Lnp Formulations And Stability Testing

5. Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies
5.2 Biotechnology Companies
5.3 Contract Research Organizations (Cros)
5.4 Vaccine Manufacturers
5.5 Academic And Research Institutions

6. Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Size, Comparisons And Growth Rate Analysis
7.3. Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Segmentation

9.1. Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Messenger Ribonucleic Acid (mRNA) Drug Synthesis, Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis
9.2. Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Preclinical, Clinical, Commercial
9.3. Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Infectious Diseases, Oncology, Other Therapeutic Areas
9.4. Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Vaccine Production, Therapeutic Development, Drug Discovery, Other Applications
9.5. Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Sub-Segmentation Of Messenger Ribonucleic Acid (mRNA) Drug Synthesis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Custom Messenger Ribonucleic Acid (mRNA) Synthesis, GMP-Grade Messenger Ribonucleic Acid (mRNA) Synthesis, Large-Scale Messenger Ribonucleic Acid (mRNA) Synthesis, Modified Messenger Ribonucleic Acid (mRNA) Synthesis, Capping And Tailing Services, Purification Services
9.6. Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Sub-Segmentation Of Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Preclinical Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, Clinical-Grade Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, GMP-Compliant Vaccine Batch Production, Self-Amplifying Messenger Ribonucleic Acid (mRNA) Synthesis, Messenger Ribonucleic Acid (mRNA)-LNP Formulation Services For Vaccines, Stability Testing And QC Services

10. Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Regional And Country Analysis

10.1. Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

11.1. Asia-Pacific Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

12.1. China Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

13.1. India Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

14.1. Japan Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

15.1. Australia Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

16.1. Indonesia Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

17.1. South Korea Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

18.1. Taiwan Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

19.1. South East Asia Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

20.1. Western Europe Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

21.1. UK Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

22.1. Germany Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

23.1. France Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

24.1. Italy Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

25.1. Spain Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

26.1. Eastern Europe Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

27.1. Russia Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

28.1. North America Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

29.1. USA Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

30.1. Canada Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

31.1. South America Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

32.1. Brazil Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

33.1. Middle East Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

34.1. Africa Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market, Segmentation By Service Type, Segmentation By Scale Of Operation, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Regulatory and Investment Landscape

36. Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Competitive Landscape And Company Profiles

36.1. Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Company Profiles
- 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. BioNTech SE Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. AGC Biologics A/S Overview, Products and Services, Strategy and Financial Analysis

37. Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Other Major And Innovative Companies

Eurofins Scientific SE, Lonza Group AG, Catalent Inc., WuXi Biologics (Cayman) Inc., Samsung Biologics Co Ltd., GenScript Biotech Corporation, Arcturus Therapeutics Holdings Inc., New England Biolabs Inc., CureVac N.V., Abzena plc, Creative Biolabs Inc., Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC

38. Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market

40. Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market High Potential Countries, Segments and Strategies

40.1 Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market In 2030 - Countries Offering Most New Opportunities
40.2 Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market In 2030 - Segments Offering Most New Opportunities
40.3 Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer